Multiple sclerosis and related disorders
Real-world effectiveness and safety of ofatumumab in relapsing multiple sclerosis: A multicenter cohort study.
Katarina Tešija, Magdalena Krbot Skorić, Vanja Bašić Kes, Lucija Zadro Matovina, Josip Sremec, Dora Vogrinc, Vladimira Vuletić, David Bonifačić, Sanda Pavelin, Ines Lazibat, Spomenka Kiđemet Piskač, Dominik Piskač, Andrijana Bogoje Raspopović, Lidija Dežmalj Grbelja, Mašan Sredanović
Published: 202610.1016/j.msard.2026.106994
Abstract
AIM: To evaluate the real-world effectiveness, safety, and tolerability of ofatumumab in people with relapsing multiple sclerosis (pwMS) in Croatia. METHODS: We conducted a retrospective observational study in eight Croatian hospitals (March 2022-Mar…
Preview only. Read the full abstract at the source